Abstract:Transient receptor potential melastatin 2 (TRPM2), a non-selective cation channel, is involved in many physiological and pathological processes, including temperature sensing, synaptic plasticity regulation, and neurodegenerative diseases. However, the gating mechanism of TRPM2 channel is complex, which hinders its functional research. With the discovery of the Ca2+ binding site in the S2-S3 domain of TRPM2 channel, more and more attention has been drawn to the role of the transmembrane segments in channel gating. In this study, we focused on the D820-F867 segment around the S2 domain, and identified the key residues on it. Functional assays of the deletion mutants displayed that the deletions of D820-W835 and L836-P851 destroyed channel function totally, indicating the importance of these two segments. Sequence alignments on them found three polar and charged residues with high conservation (D820, E829, and R845). D820A, E829A, and R845A which removed the charge and the side chain of the residues were tested by 500 mu M adenosine diphosphate-ribose (ADPR) or 50 mM Ca2+. E829A and R845A affected the characteristic of channel currents, while D820A behaved similarly to WT, indicating the participations of E829 and R845 in channel gating. The charge reversing mutants, E829K and R845D were then constructed and the electrophysiological tests showed that E829A and E829K made the channel lose function. Interestingly, R845A and R845D exhibited an inactivation process when using 500 mu M ADPR, but activated normally by 50 mM Ca2+. Our data suggested that the negative charge at E829 took a vital part in channel activation, and R845 increased the stability of the Ca2+ combination in S2-S3 domain, thus guaranteeing the opening of TRPM2 channel. In summary, our identification of the key residues E829 and R845 in the transmembrane segments of TRPM2. By exploring the gating process of TRPM2 channel, our work helps us better understand the mechanism of TRPM2 as a potential biomarker in neurodegenerative diseases, and provides a new approach for the prediction, diagnosis, and prognosis of neurodegenerative diseases.

Inactivation of Trpm2 Channels by Extracellular Divalent Copper

Zinc Inactivates Melastatin Transient Receptor Potential 2 Channels Via the Outer Pore

Effects of Calcium-Binding Sites in the S2–S3 Loop on Human and Nematostella Vectensis TRPM2 Channel Gating Processes

Divalent cations activate TRPV1 through promoting conformational change of the extracellular region.

Divalent cations potentiate TRPV1 channel by lowering the heat activation threshold.

Selective disruption of high sensitivity heat activation but not capsaicin activation of TRPV1 channels by pore turret mutations.

The identification of the key residues E829 and R845 involved in transient receptor potential melastatin 2 channel gating

State-dependent Inhibition of TRPM2 Channel by Acidic Ph

Copper Increases the Cooperative Gating of Rat P2X2a Receptor Channels

Decreasing Expression of Alpha(1c) Calcium L-Type Channel Subunit Mrna in Rat Ventricular Myocytes Upon Manganese Exposure

Mechanism of Proton Inhibition of TRPV3

Interaction of Divalent Metal Ions with the Carboxyl-Terminal Domain of Human Voltage-Gated Proton Channel Hv1

Mechanisms of Proton Inhibition and Sensitization of the Cation Channel TRPV3.

Intracellular Helix-Loop-Helix Domain Modulates Inactivation Kinetics of Mammalian TRPV5 and TRPV6 Channels

Effects of TRPC1's Lysines on Heteromeric TRPC5-TRPC1 Channel Function

Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7

TRPM7 is Regulated by Halides Through Its Kinase Domain.

Aberrant Deactivation-Induced Gain of Function in TRPM4 Mutant Is Associated with Human Cardiac Conduction Block.

Conservation of the cooling agent binding pocket within the TRPM subfamily

Bimodal voltage dependence of TRPA1: mutations of a key pore helix residue reveal strong intrinsic voltage-dependent inactivation

Inhibiting Effects of Common Trivalent Metal Ions on Transmembrane-Type 2 Matrix Metalloproteinase.